Northwestern Mutual Wealth Management
GTBP icon

Northwestern Mutual Wealth Management’s GT Biopharma GTBP Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-5
Closed -$136 – 3460
2022
Q4 		$136 Buy
+5
New +$250 ﹤0.01% 3210

Other funds holding GTBP

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFS
Baskin Financial Services Toronto, Ontario, Canada $1.27B AUM 9.68% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northwestern Mutual Wealth Management's GTBP Position: Q1 2023 in Review

Northwestern Mutual Wealth Management sold out of GT Biopharma (GTBP) in Q1 2023, closing a stake of 5 shares — an estimated $136 sold.

Northwestern Mutual Wealth Management first reported a position in GTBP in Q4 2022 and held it in 1 quarter. The position peaked at $136 in Q4 2022. 35 funds tracked by Wall St. Rank hold GTBP as of Q1 2023.

  • Northwestern Mutual Wealth Management reported no remaining GT Biopharma position as of Q1 2023 after selling out during the quarter.
  • Northwestern Mutual Wealth Management sold 5 GT Biopharma shares in Q1 2023, an estimated $136.
  • Northwestern Mutual Wealth Management first reported a position in GT Biopharma in Q4 2022 and held it in 1 quarter.
  • Northwestern Mutual Wealth Management's GT Biopharma position peaked at $136 in Q4 2022.
  • 35 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2023.

Based on Northwestern Mutual Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.